Antihypertensive Treatment in Kidney Transplant Recipients—A Current Single Center Experience
Arterial hypertension affects the survival of the kidney graft and the cardiovascular morbidity and mortality of the recipient after kidney transplantation (KTx). Thus, antihypertensive treatment is necessary for a vast majority of these patients. Long-term data on antihypertensive drugs and their e...
Main Authors: | Ulrich Jehn, Katharina Schütte-Nütgen, Markus Strauss, Jan Kunert, Hermann Pavenstädt, Gerold Thölking, Barbara Suwelack, Stefan Reuter |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/12/3969 |
Similar Items
-
The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation
by: Gerold Thölking, et al.
Published: (2021-07-01) -
Cytomegalovirus Viremia after Living and Deceased Donation in Kidney Transplantation
by: Ulrich Jehn, et al.
Published: (2020-01-01) -
The Effect of Proton Pump Inhibitor Use on Renal Function in Kidney Transplanted Patients
by: Dominik J. G. Flothow, et al.
Published: (2020-01-01) -
Prognostic Value of Growth Differentiation Factor 15 in Kidney Donors and Recipients
by: Ulrich Jehn, et al.
Published: (2020-05-01) -
Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
by: Gerold Thölking, et al.
Published: (2020-01-01)